Jci_page_head_homepage_01 Jci_page_head_homepage_02
Franck Mauvais-Jarvis, Kohjiro Ueki, David A. Fruman, Michael F. Hirshman, Kei Sakamoto, Laurie J. Goodyear, Matteo Iannacone, Domenico Accili, Lewis C. Cantley, C. Ronald Kahn
Published in Volume 109, Issue 1
J Clin Invest. 2002; 109(1):141–149 doi:10.1172/JCI13305
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

PI 3-kinase activation in liver and muscle of Pik3r1 mutant mice. Lysates from the liver of animals were immunoprecipitated with the indicated antibodies and subjected to a PI 3-kinase assay as described in Methods. PI 3-kinase activities associated with total regulatory subunit (αp85pan) (a), associated with p85α regulatory subunit (αp85α) (b), associated with the p110 catalytic subunit (αp110) (c), associated with tyrosine-phosphorylated proteins (αPY) (d), and associated with p85β regulatory subunit (αp85β) (e) were assessed. The upper panels shows representative PI 3-kinase assays, while each bar in the lower panels represents the mean ± SEM of the relative PI 3-kinase activity (% of unstimulated wild-type) calculated from at least three independent experiments. *P < 0.05, wild-type vs. p85+/–. (f) Activation of PI 3-kinase in muscle. Lysates were immunoprecipitated with the p85pan antibody (αp85pan, top panel), tyrosine-phosphorylated proteins (αPY, middle panel), or the p85β regulatory subunit (αp85β, bottom panel), and subjected to PI 3-kinase assay as above.